Algorae Pharmaceuticals Ltd - Company Profile
Powered by 
All the data and insights you need on Algorae Pharmaceuticals Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Algorae Pharmaceuticals Ltd Strategy Report
- Understand Algorae Pharmaceuticals Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Algorae Pharmaceuticals Ltd’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 25 Jan 2018 | Living Cell Technologies to Enter into Licensing Agreement with Diatranz Otsuka | Licensing Agreement |
Algorae Pharmaceuticals Ltd
|
Diatranz Otsuka Ltd
|
| 25 Jan 2018 | Otsuka Pharma Acquires 50% Stake in Diatranz Otsuka from Living Cell Technologies | Acquisition |
Otsuka Pharmaceutical Factory Inc
|
Diatranz Otsuka Ltd
|
| 16 May 2017 | Living Cell Technologies Enters into Research Agreement with The Centre for Brain Research | Partnership | - |
The Centre for Brain Research
Algorae Pharmaceuticals Ltd |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer